Certified by Founder Lodge
MapLight Therapeutics, Inc.
United States - Palo Alto, CA
START UP
1 Disclosed Funding Rounds $225,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Maplight is a biopharmaceutical company discovering and developing novel therapeutics for patients with disorders of the central nervous system (CNS).
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 31 ,2023 | Series C | $225,000,000 |
Novo Holdings
5AM Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
OneChronos | $32,000,000 | (Nov 20, 2024)
Kalder | $10,500,000 | (Nov 20, 2024)
Jimini Health | $8,000,000 | (Nov 20, 2024)
RIIG | $3,000,000 | (Nov 20, 2024)
EarthOptics | $24,000,000 | (Nov 20, 2024)
